Resnick Andrew, Chait Michael, Landau Steven, Krishnan Sandeep
Department of Anesthesiology, Wayne State University School of Medicine, Detroit.
Department of Anesthesiology, St. Joseph Mercy Oakland Hospital, Pontiac, MI, USA.
Medicine (Baltimore). 2020 Oct 2;99(40):e22477. doi: 10.1097/MD.0000000000022477.
Percutaneous nephrolithotomy is a procedure used for management of refractory renal calculi. Oral and parenteral opioids, along with local anesthetic infiltration, neuraxial anesthesia, and paravertebral blocks are the most common methods of managing intra-operative and post-operative pain for these patients. The erector spinae plane block with catheter (ESPC) is a newer interfascial regional anesthetic technique that can be used to manage peri-operative pain in these patients.
Three patients complained of significant flank pain were scheduled for percutaneous nephrolithotomy under general anesthesia in the prone position.
Patients were diagnosed with large renal calculi.
Patients received ESPC in the pre-operative holding area at the level of the T7 transverse process. The ESPCS were bolused with a solution of 30 mL 0.25% bupivacaine with 4 mg dexamethasone prior to surgery. Patients also received oral tramadol 50 mg and acetaminophen 1 g as part of the multimodal pain protocol prior to surgery. After the procedure, the patients were bolused with 0.25% bupivacaine or started on an infusion of 0.25% bupivacaine to manage their pain.
No opioid or other pain medications, other than the local anesthetic solution given in the ESPCs, were used during the intra-operative or post-operative period for management of pain in these patients. Visual analogue scale (VAS) scores were below 4 for all patients in the post-operative period, and patients did not report any issues with post-operative nausea or vomiting.
These patients were compared to 3 prior patients who had undergone percutaneous nephrolithotomy without ESPC. The 3 patients without ESPC placement reported increased VAS scores, had increased opioid/pain medication consumption intraoperatively and postoperatively, and had increased incidence of perioperative nausea when compared to our ESPC patients. Our report shows that ESPC, in combination with a multimodal pain protocol, can be a good option for management of patients undergoing percutaneous nephrolithotomy.
经皮肾镜取石术是一种用于治疗难治性肾结石的手术。口服和胃肠外阿片类药物,以及局部麻醉药浸润、神经轴阻滞和椎旁阻滞是这些患者术中及术后疼痛管理的最常用方法。带导管的竖脊肌平面阻滞(ESPC)是一种较新的筋膜间区域麻醉技术,可用于这些患者围手术期疼痛的管理。
三名主诉严重胁腹疼痛的患者计划在全身麻醉下俯卧位进行经皮肾镜取石术。
患者被诊断为巨大肾结石。
患者在术前等待区T7横突水平接受ESPC。术前,ESPC用30毫升0.25%布比卡因加4毫克地塞米松溶液推注。患者术前还接受了口服曲马多50毫克和对乙酰氨基酚1克,作为多模式疼痛方案的一部分。手术后,患者用0.25%布比卡因推注或开始输注0.25%布比卡因以控制疼痛。
在术中或术后期间,这些患者除了ESPC中给予的局部麻醉溶液外,未使用其他阿片类药物或其他止痛药物来控制疼痛。术后所有患者的视觉模拟评分(VAS)均低于4分,且患者未报告任何术后恶心或呕吐问题。
将这些患者与3名之前未接受ESPC而进行经皮肾镜取石术的患者进行比较。与我们的ESPC患者相比,3名未放置ESPC的患者报告VAS评分升高,术中及术后阿片类药物/止痛药物消耗量增加,围手术期恶心发生率增加。我们的报告表明,ESPC与多模式疼痛方案相结合,可能是经皮肾镜取石术患者管理的一个良好选择。